Hong Kong-based Insilico Medicine has agreed an artificial intelligence breast cancer drug discovery partnership worth a potential $200 million with a Chinese pharmaceutical company.
Goldfinch Bio, a US company focused on developing treatments for kidney disease, has agreed to license a cannabinoid receptor 1 antibody from Japanese pharmaceutical manufacturer Takeda.
Novartis has teamed with Microsoft to launch a new artificial intelligence innovation lab, which it says has the potential to “transform” and “reimagine” medicine.
Evolve BioSystems and the University of California have jointly sued Abbott Laboratories for patent infringement over a soon-to-be-launched probiotic product.
The US Court of Appeals for the Federal Circuit has ruled that delays resulting from challenges to patent examiners’ final decisions will be attributed to the applicant when calculating patent term adjustment.
Advocate general Henrik Saugmandsgaard Øe has advised Europe’s highest court on the scope of protection held by owners of plant variety rights.
The US Court of Appeals for the Federal Circuit has affirmed the US Patent and Trademark Office’s patent term adjustment of a Mayo Foundation-owned patent.
A couple who worked at Ohio-based research institute Nationwide Children’s Hospital have been charged with stealing trade secrets and then using the information to market products through their Chinese company.
Taiwanese company JHL Biotech will stop developing biosimilar versions of Genentech’s drugs as part of a memorandum of understanding signed by the parties to end trade secrets litigation.
IP services company Clarivate Analytics has acquired patent sequence information provider SequenceBase to expand its search and analysis capabilities for the life sciences IP market.